376 results on '"Provero, Paolo"'
Search Results
2. Stroma-derived miR-214 coordinates tumor dissemination
3. Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses
4. Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer
5. IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions
6. Differential selective regimes identify categories of transposable elements with regulatory function
7. FLVCR1a Controls Cellular Cholesterol Levels through the Regulation of Heme Biosynthesis and Tricarboxylic Acid Cycle Flux in Endothelial Cells
8. MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer
9. STAT3-dependent long non-coding RNA Lncenc1 contributes to mouse ES cells pluripotency via stabilizing Klf4 mRNA
10. A fluorescent reporter model for the visualization and characterization of TDC
11. Pseudogenes as Competitive Endogenous RNAs: Target Prediction and Validation
12. Optic nerve sheath diameter asymmetry in healthy subjects and patients with intracranial hypertension
13. The BioMart community portal: an innovative alternative to large, centralized data repositories.
14. Figure S5 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
15. Table 1 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
16. Table 2 from miR-146a Exerts Differential Effects on Melanoma Growth and Metastatization
17. eQTL Mapping Using Transcription Factor Affinity
18. miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling
19. Ancestral genetic components are consistently associated with the complex trait landscape in European biobanks
20. A fluorescent reporter model for the visualization and characterization of TDC.
21. Supplementary Tables 1 and 2 and Supplementary Figures 1 through 6 from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
22. Data from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
23. Supplementary Table S3 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
24. Supplementary Methods, Results and Tables from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
25. Supplementary Figure Legends from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
26. Data from Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation
27. Supplementary Materials and Methods from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
28. Supplementary Figure S3 from Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma
29. Supplementary Figures from Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer
30. Supplementary Data 1 from Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma
31. Data from Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten
32. Figure S2 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
33. Supplementary from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
34. Data from Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
35. Data from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
36. Supplemental Figure S1 from Targeting Cancer Stem–like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma
37. Data from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
38. Data from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
39. Supplementary Methods, Figures 1-8, Table 1 from Constitutively Active Stat3 Enhances Neu-Mediated Migration and Metastasis in Mammary Tumors via Upregulation of Cten
40. Supplementary Data 3 from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
41. Supplementary Data 1 from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
42. Table S1 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
43. Supplementary Data 2 from EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
44. Supplemental Figure Legends from Targeting Cancer Stem–like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma
45. Supplementary Data S3 from Development of Ewing's Sarcoma from Primary Bone Marrow–Derived Mesenchymal Progenitor Cells
46. Supplementary Data 2 from Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma
47. Supplementary Data 3 from Expression of the FUS-CHOP Fusion Protein in Primary Mesenchymal Progenitor Cells Gives Rise to a Model of Myxoid Liposarcoma
48. Supplementary Data Legends 1-3 from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
49. Supplemental Table S1 from Targeting Cancer Stem–like Cells as an Approach to Defeating Cellular Heterogeneity in Ewing Sarcoma
50. Supplementary Data 2 from EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.